Zomedica (NYSE American: ZOM), a veterinary health company offering diagnostic and therapeutic products for companion animals, announced a strategic restructuring of its existing development and commercialization agreements with Qorvo Biotechnologies for the Company's TRUFORMA® line of products. Under the agreements, Zomedica will take control of aspects of the TRUFORMA product line previously provided by Qorvo, including development of new assays and manufacturing both instruments and assay cartridges. This positions Zomedica to invest in accelerated development of new TRUFORMA assays and to improve margins once it begins manufacturing directly.

Genius Group (NYSE American: GNS), a leading entrepreneur edtech and education group, announced the creation of a Board-led ‘Illegal Trading Task Force’ to actively pursue all possible actions together with the regulators in their discovery and prosecution of persons engaging in market manipulation involving the ordinary shares of Genius Group. This Task Force will be led by Timothy Murphy, a Genius Group Director and former Deputy Director of the F.B.I., Richard Berman, also a Genius Group Director and chair of the Company’s Audit Committee, and Roger Hamilton, the CEO of Genius Group.

Rail Vision (Nasdaq: RVSN), a technology company that is seeking to revolutionize railway safety and the data-related market, appointed rail industry veteran Mark Cleobury as Chairman of the Board. “Mark’s appointment to Chairman of the Board comes at a transformational time for Rail Vision as we enter a period of expected accelerated growth,” commented Rail Vision CEO Shahar Hania. “I believe Mark’s wealth of experience will prove invaluable to Rail Vision as we continue to drive our mission of becoming a global leader in railway obstacle detection and data solutions.”

American Resources Corporation (Nasdaq: AREC), a next generation and socially responsible supplier of rare earth and critical elements, carbon and advanced carbon materials, today announced that its wholly-owned subsidiary, ReElement Technologies LLC, has entered into a MOU with Continental Lithium to begin trial shipments of lithium spodumene ore to ReElement Technologies' Noblesville, Indiana facility to refine into high-purity (99.9%+) lithium carbonate or lithium hydroxide using the Company's patented and revolutionary multi-mode chromatography technology.